This market insight covers the growth opportunities for personal protective equipment (PPE) in the pharmaceutical industry. The study addresses key aspects such as market drivers and restraints, key regulations, the impact of policy changes, and the potential for growth for pharmaceutical PPE in key applications.
Market drivers and restraints have been discussed for the period 2017–2021. Insights into key regulations governing pharmaceutical PPE are provided for the major market segments. Broader trends in the pharmaceutical industry such as spending on medicines, growth in generic drugs, and the rise of contract manufacturing organizations that are expected to impact PPE use and sales are also covered. Transformations that characterize the pharmaceutical PPE ecosystem are provided, along with the growth opportunities for pharmaceutical PPE manufacturers. Revenue estimates for the pharmaceutical PPE market are also tabled. Insights into the impact of policy changes on PPE usage at the federal level are provided, along with the strategic imperatives for growth and success. Selection criteria for PPE are also included.
The following segments are covered:
• Head protection
• Eye and face protection
• Protective clothing
• Protective gloves
• Protective eye-wear
• Protective footwear
Industry hazards including physical hazards, ergonomic hazards, chemical hazards, physical hazards, mechanical hazards, fire and explosion hazards, and gas hazards present in the PPE environment are identified, along with the degree of risk to workers and the potential for PPE usage. The use of PPE, such as head, eye and face, hearing, and respiratory protection, protective gloves, protective clothing, and protective footwear, in key occupations is identified.
Information on the degree of compliance and price sensitivity are provided and the level of requirement and risk is analyzed. The fastest growing segments in the pharmaceutical PPE industry are also identified. Additionally, insights into major market trends that are likely to characterize the pharmaceutical PPE market are provided.